Astera Labs price target raised to $225 from $200 at Roth Capital

Roth Capital raised the firm’s price target on Astera Labs (ALAB) to $225 from $200 and keeps a Buy rating on the shares. The company reported solid results and guidance reflecting a continued healthy ramp across multiple product lines, and the firm is encouraged that Astera continues to gain traction into larger and higher average sales prices scale-up connectivity markets across a broadening range of hyperscale customers, the analyst tells investors in a research note.